The global antimicrobial susceptibility testing market stands at USD 3.5 billion in 2026 and is projected to expand to USD 5.0 billion by 2036, reflecting a steady CAGR of 3.6%. This measured growth responds directly to the escalating global burden of antimicrobial resistance (AMR), recognized by the World Health Organization as one of the top 10 public health threats. Accurate...